Sensei Biotherapeutics is an immuno-oncology company that is dedicated to understanding and selectively interacting with the tumor microenvironment in order to tilt the immune system against cancer. We are leveraging our TMAb™ platform to develop highly selective therapeutics that have the potential to alter the relationship between host immune cells and cancer so that the tumor is recognized and treated as if it were an infection. Our team is comprised of lifelong learners striving for insight at the intersection of immunology, oncology and biology. We are driven to apply our scientific curiosity to the critical needs faced daily by people who are diagnosed with cancer and the physicians who treat them. We stay humble, always follow the data, and believe that our deep knowledge of cancer biology, the tumor microenvironment, and immunology will lead us to effective therapies.
View Top Employees from Sensei BioWebsite | https://www.senseibio.com |
Revenue | $8 million |
Funding | $211.1 million |
Employees | 42 (42 on RocketReach) |
Founded | 1999 |
Address | 1405 Research Blvd Suite 125, Rockville, Maryland 20850, US |
Phone | (240) 243-8000 |
Technologies |
JavaScript,
HTML,
PHP
+30 more
(view full list)
|
Industry | Biotechnology, Drug Manufacturing & Research, Drug Discovery, Pharmaceuticals, Healthcare |
Competitors | Adagene, Atreca, Inc., Cel-Sci, Galera Therapeutics, Inc., Synthorx Inc |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Sensei Bio employee's phone or email?
The Sensei Bio annual revenue was $8 million in 2024.
Alice Drumheller is the Vice President Clinical Operations of Sensei Bio.
42 people are employed at Sensei Bio.
Sensei Bio is based in Rockville, Maryland.
The NAICS codes for Sensei Bio are [54, 541, 325, 32541, 3254, 32].
The SIC codes for Sensei Bio are [283, 28].